Declaration Partners

The investment enables CP Group to expand its engineering and research capabilities.

Investors include Declaration Partners, Euclidean Capital and True North Advisors.

Declaration Partners’ deal is part of a wave of GP-led activity this year firms are using to try and generate proceeds for their investors.

The deal would allow Rubenstein to sell partial stakes in several assets, which will support his investment in the Baltimore Orioles Major League Baseball franchise, sources said.

Declaration Partners is eyeing deals in Africa which can have better risk-reward trade-offs, says its owner and Carlyle Group co-founder.

Tough sledding for distressed-focused managers, Peaceable Street reaches deal with Declaration Partners

Amperity said July 15 that it raised a $50 million Series C round from Tiger Global Management, Goldman Sachs, Declaration Partners (an investment firm backed by David Rubenstein), Madera Technology Partners, Madrona Venture Group, and investor Lee Fixel. Amperity provides a AI-powered customer data management platform.

aXiomatic said Oct. 25 that Michael Jordan and Declaration Capital, the family office of David Rubenstein, have invested in the company. Financial terms weren’t announced although press reports pegged the round at $26 million. Curtis Polk, managing partner and alternate governor of Hornets Sports & Entertainment, is also investing. aXiomatic, of Los Angeles, is an esports and video game startup. George P. Stamas of Gibson, Dunn & Crutcher was aXiomatic’s counsel for the funding round.

US states are piling more pressure onto private equity healthcare teams. Plus: a new Vitruvian man; and Carlyle co-founder David Rubenstein has come into some liquidity. Here's today's brief, for our valued subscribers only.

The Bank of England has concerns over the private equity industry's resilience to economic shocks. Plus: why some GPs are breaking private equity's 'unwritten' fundraising rule. Here's today's brief, for our valued subscribers only.

SWaN & Legend, T. Rowe Price and Revolution Growth collectively own about 33.8m shares valued at nearly $1.5bn based on the closing price of $43.30.

Building out technology in old-line businesses is a way to potentially make them more valuable, which can serve as a hedge to rising rates and potential lower exit multiples in the future.

The firm, like other first-timers in the market, is raising a fund at a time of slowing fundraising and LP hesitancy to back new teams as they stick with their established relationships.

Primed by a vigorous deal environment, tech PE fundraising rose to dizzying heights in 2021, with 474 North American vehicles collecting an all-time high of $227bn, according to Buyouts data.

San Diego-based PetDx, a liquid biopsy company for pets, has raised $62 million in Series B funding.

Copado, a DevOps platform, has raised $140 million in Series C funding.